SCHEMBL25013430

SCHEMBL25013430

CC(=O)O[C@H]([C@@H](COCN[C@@H](C)C(=O)OC(C)C)OC#N)[C@@H](OC(C)=O)c1ccc2c(N)ncnn12

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RIPK1 Q13546 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25013997 0.93 — —
SCHEMBL25013432 0.92 RIPK1 (0.30) RIPK1
SCHEMBL25013954 0.91 — —
SCHEMBL26316679 0.87 RIPK1 (0.31) RIPK1
SCHEMBL25012688 0.85 — —
SCHEMBL25012471 0.85 — —
SCHEMBL26214112 0.82 — —
SCHEMBL26317664 0.81 RIPK1 (0.33) RIPK1
SCHEMBL26317120 0.79 RIPK1 (0.31) RIPK1
SCHEMBL23819007 0.79 RIPK1 (0.30) RIPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040586-A1 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF GILEAD SCIENCES, INC. 2023-02-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230040586-A1 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF TYMP, PNP, DUT RIPK1 4480/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback